264 related articles for article (PubMed ID: 23510779)
1. Association of the I148M/PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight/obese Mexican children.
Larrieta-Carrasco E; León-Mimila P; Villarreal-Molina T; Villamil-Ramírez H; Romero-Hidalgo S; Jacobo-Albavera L; Gutiérrez-Vidal R; López-Contreras BE; Guillén-Pineda LE; Sánchez-Muñoz F; Bojalil R; Mejía-Domínguez AM; Méndez-Sánchez N; Domínguez-López A; Aguilar-Salinas CA; Canizales-Quinteros S
Gene; 2013 May; 520(2):185-8. PubMed ID: 23510779
[TBL] [Abstract][Full Text] [Related]
2. Associations of I148M variant in PNPLA3 gene with plasma ALT levels during 2-year follow-up in normal weight and overweight children: the PANIC Study.
Viitasalo A; Pihlajamaki J; Lindi V; Atalay M; Kaminska D; Joro R; Lakka TA
Pediatr Obes; 2015 Apr; 10(2):84-90. PubMed ID: 24916969
[TBL] [Abstract][Full Text] [Related]
3. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
Romeo S; Sentinelli F; Cambuli VM; Incani M; Congiu T; Matta V; Pilia S; Huang-Doran I; Cossu E; Loche S; Baroni MG
J Hepatol; 2010 Aug; 53(2):335-8. PubMed ID: 20546964
[TBL] [Abstract][Full Text] [Related]
4. PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations.
Larrieta-Carrasco E; Acuña-Alonzo V; Velázquez-Cruz R; Barquera-Lozano R; León-Mimila P; Villamil-Ramírez H; Menjivar M; Romero-Hidalgo S; Méndez-Sánchez N; Cárdenas V; Bañuelos-Moreno M; Flores YN; Quiterio M; Salmerón J; Sánchez-Muñoz F; Villarreal-Molina T; Aguilar-Salinas CA; Canizales-Quinteros S
Mol Biol Rep; 2014 Jul; 41(7):4705-11. PubMed ID: 24691744
[TBL] [Abstract][Full Text] [Related]
5. Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.
Flores YN; Velázquez-Cruz R; Ramírez P; Bañuelos M; Zhang ZF; Yee HF; Chang SC; Canizales-Quinteros S; Quiterio M; Cabrera-Alvarez G; Patiño N; Salmerón J
Mol Biol Rep; 2016 Dec; 43(12):1359-1369. PubMed ID: 27752939
[TBL] [Abstract][Full Text] [Related]
6. Association of ALT and the metabolic syndrome among Mexican children.
Elizondo-Montemayor L; Ugalde-Casas PA; Lam-Franco L; Bustamante-Careaga H; Serrano-González M; Gutiérrez NG; Martínez U
Obes Res Clin Pract; 2014; 8(1):e79-87. PubMed ID: 24548580
[TBL] [Abstract][Full Text] [Related]
7. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L
Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
[TBL] [Abstract][Full Text] [Related]
8. Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.
Hyysalo J; Gopalacharyulu P; Bian H; Hyötyläinen T; Leivonen M; Jaser N; Juuti A; Honka MJ; Nuutila P; Olkkonen VM; Oresic M; Yki-Järvinen H
Diabetes; 2014 Jan; 63(1):312-22. PubMed ID: 24009255
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.
Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R
Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of alanine aminotransferase elevation among normal weight, overweight and obese youth in Mexico.
Purcell M; Flores YN; Zhang ZF; Denova-Gutiérrez E; Salmeron J
J Dig Dis; 2013 Sep; 14(9):491-9. PubMed ID: 23678860
[TBL] [Abstract][Full Text] [Related]
11. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
Donati B; Motta BM; Pingitore P; Meroni M; Pietrelli A; Alisi A; Petta S; Xing C; Dongiovanni P; del Menico B; Rametta R; Mancina RM; Badiali S; Fracanzani AL; Craxì A; Fargion S; Nobili V; Romeo S; Valenti L
Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
[TBL] [Abstract][Full Text] [Related]
12. Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study.
Posadas-Sánchez R; López-Uribe ÁR; Posadas-Romero C; Pérez-Hernández N; Rodríguez-Pérez JM; Ocampo-Arcos WA; Fragoso JM; Cardoso-Saldaña G; Vargas-Alarcón G
Immunobiology; 2017 Oct; 222(10):960-966. PubMed ID: 27615511
[TBL] [Abstract][Full Text] [Related]
13. The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat.
Giudice EM; Grandone A; Cirillo G; Santoro N; Amato A; Brienza C; Savarese P; Marzuillo P; Perrone L
PLoS One; 2011; 6(11):e27933. PubMed ID: 22140488
[TBL] [Abstract][Full Text] [Related]
14. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis.
Di Bonito P; Sanguigno E; Di Fraia T; Forziato C; Boccia G; Saitta F; Iardino MR; Capaldo B
Metabolism; 2009 Mar; 58(3):368-72. PubMed ID: 19217453
[TBL] [Abstract][Full Text] [Related]
15. More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3.
Chinchilla-López P; Ramírez-Pérez O; Cruz-Ramón V; Canizales-Quinteros S; Domínguez-López A; Ponciano-Rodríguez G; Sánchez-Muñoz F; Méndez-Sánchez N
Ann Hepatol; 2018 Mar; 17(2):250-255. PubMed ID: 29469042
[TBL] [Abstract][Full Text] [Related]
16. The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients.
Luukkonen PK; Qadri S; Lehtimäki TE; Juuti A; Sammalkorpi H; Penttilä AK; Hakkarainen A; Orho-Melander M; Arola J; Yki-Järvinen H
J Clin Endocrinol Metab; 2021 Jan; 106(1):e300-e315. PubMed ID: 33064150
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
Rametta R; Ruscica M; Dongiovanni P; Macchi C; Fracanzani AL; Steffani L; Fargion S; Magni P; Valenti L
Eur J Clin Invest; 2014 Jul; 44(7):627-33. PubMed ID: 24828988
[TBL] [Abstract][Full Text] [Related]
18. The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.
Di Sessa A; Umano GR; Cirillo G; Del Prete A; Iacomino R; Marzuillo P; Del Giudice EM
J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):69-74. PubMed ID: 29601441
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents.
Strauss RS; Barlow SE; Dietz WH
J Pediatr; 2000 Jun; 136(6):727-33. PubMed ID: 10839867
[TBL] [Abstract][Full Text] [Related]
20. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL
Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]